A post-mortem study of human pancreases demonstrated proliferative effects in those cases with GLP-1RA use, which were manifest by an increased mass of the pancreas along with increased frequency of PanIN1 and PanIN2 lesions compared to diabetes controls 23
In one trial, these side effects caused around 4%7% of people to stop using Zepbound
PubMed: Tirzepatide weight loss research , searchable database of peer-reviewed studies on tirzepatide efficacy and safety
This cascade effect represents one of the most significant advantages of GLP-1 pathway support over traditional weight loss approaches
It is marketed under two brand names: Zepbound (FDA-approved for chronic weight management) Mounjaro (primarily prescribed for type 2 diabetes) Each pen comes in graduated dosage strengths, supporting a stepwise dosing approach that helps improve tolerability and effectiveness over time
Accessibility & Affordability Compounded GLP-1 + GIP Women choose compounded options because they are: Often more affordable Easier to obtain when branded medications are limited Customizable in dosage Available through telehealth programs like Alternate Health Club Ozempic Branded medications can be: Expensive without insurance Sometimes back-ordered Harder to access depending on your state Many women switch to compounded options because they need reliable access every month while staying within budget